Suppr超能文献

由于RLIP76缺失导致药物转运减少和辐射敏感性增强。

Diminished drug transport and augmented radiation sensitivity caused by loss of RLIP76.

作者信息

Singhal Sharad S, Yadav Sushma, Singhal Jyotsana, Sahu Mukesh, Sehrawat Archana, Awasthi Sanjay

机构信息

Department of Molecular Biology and Immunology, University of North Texas Health Science Center, 3500 Camp Bowie Boulevard, EAD RM No. 542, Fort Worth, TX 76107-2699, United States.

出版信息

FEBS Lett. 2008 Oct 15;582(23-24):3408-14. doi: 10.1016/j.febslet.2008.09.001. Epub 2008 Sep 18.

Abstract

This study was undertaken to characterize the consequences of Ral-interacting protein (RLIP76)-loss with respect to drug resistance, transport, radiation resistance, and alternative transport mechanisms in mouse embryonic fibroblasts (MEFs). MEFs were derived from RLIP76+/+, RLIP76+/- and RLIP76-/- mice. The transport of doxorubicin (DOX), colchicine (COL), leukotriene C4 and dinitrophenyl S-glutathione (DNP-SG) was analyzed in inside-out vesicles (IOVs) prepared from MEFs. We used immuno-titration of transport activity to determine the contribution of RLIP76, MRP1, and p-glycoprotein (Pgp) towards total transport activity. Loss of RLIP76 alleles resulted in significant sensitization to radiation, DOX, cisplatin, and vinorelbine (VRL). In IOVs prepared from MEFs, we observed a stepwise loss of transport activity. Loss of RLIP76 confers sensitivity to xenobiotics and radiation due to the loss of a common transport mechanism for glutathione-electrophile conjugates and xenobiotics.

摘要

本研究旨在表征Ral相互作用蛋白(RLIP76)缺失在小鼠胚胎成纤维细胞(MEF)的耐药性、转运、抗辐射性及其他转运机制方面的后果。MEF源自RLIP76+/+、RLIP76+/-和RLIP76-/-小鼠。对从MEF制备的内翻囊泡(IOV)中阿霉素(DOX)、秋水仙碱(COL)、白三烯C4和二硝基苯基S-谷胱甘肽(DNP-SG)的转运进行了分析。我们采用转运活性的免疫滴定法来确定RLIP76、多药耐药相关蛋白1(MRP1)和P-糖蛋白(Pgp)对总转运活性的贡献。RLIP76等位基因的缺失导致对辐射、DOX、顺铂和长春瑞滨(VRL)显著敏感。在从MEF制备的IOV中,我们观察到转运活性逐步丧失。RLIP76的缺失由于谷胱甘肽-亲电试剂缀合物和外源性物质的共同转运机制丧失,从而导致对外源性物质和辐射敏感。

相似文献

1
Diminished drug transport and augmented radiation sensitivity caused by loss of RLIP76.
FEBS Lett. 2008 Oct 15;582(23-24):3408-14. doi: 10.1016/j.febslet.2008.09.001. Epub 2008 Sep 18.
2
RLIP76 is the major ATP-dependent transporter of glutathione-conjugates and doxorubicin in human erythrocytes.
Arch Biochem Biophys. 2001 Jul 15;391(2):171-9. doi: 10.1006/abbi.2001.2395.
4
Determinants of differential doxorubicin sensitivity between SCLC and NSCLC.
FEBS Lett. 2006 Apr 17;580(9):2258-64. doi: 10.1016/j.febslet.2006.03.038. Epub 2006 Mar 24.
5
RLIP76, a novel transporter catalyzing ATP-dependent efflux of xenobiotics.
Drug Metab Dispos. 2002 Dec;30(12):1300-10. doi: 10.1124/dmd.30.12.1300.
7
POB1 over-expression inhibits RLIP76-mediated transport of glutathione-conjugates, drugs and promotes apoptosis.
Biochem Biophys Res Commun. 2005 Mar 25;328(4):1003-9. doi: 10.1016/j.bbrc.2005.01.055.
9
Increased expression of cdc2 inhibits transport function of RLIP76 and promotes apoptosis.
Cancer Lett. 2009 Oct 8;283(2):152-8. doi: 10.1016/j.canlet.2009.03.033. Epub 2009 Apr 17.

引用本文的文献

1
Crucial Role of RLIP76 in Promoting Glycolysis and Tumorigenesis by Stabilization of HIF-1α in Glioma Cells Under Hypoxia.
Mol Neurobiol. 2022 Nov;59(11):6724-6739. doi: 10.1007/s12035-022-02999-w. Epub 2022 Aug 23.
2
Anticancer Activity of Ω-6 Fatty Acids through Increased 4-HNE in Breast Cancer Cells.
Cancers (Basel). 2021 Dec 20;13(24):6377. doi: 10.3390/cancers13246377.
3
Activating p53 function by targeting RLIP.
Biochim Biophys Acta Rev Cancer. 2021 Apr;1875(2):188512. doi: 10.1016/j.bbcan.2021.188512. Epub 2021 Jan 15.
4
2'-Hydroxyflavanone inhibits in vitro and in vivo growth of breast cancer cells by targeting RLIP76.
Mol Carcinog. 2018 Dec;57(12):1751-1762. doi: 10.1002/mc.22894. Epub 2018 Sep 19.
5
RLIP76 Inhibition: A Promising Developmental Therapy for Neuroblastoma.
Pharm Res. 2017 Aug;34(8):1673-1682. doi: 10.1007/s11095-017-2154-y. Epub 2017 Apr 6.
6
Antioxidant role of glutathione S-transferases: 4-Hydroxynonenal, a key molecule in stress-mediated signaling.
Toxicol Appl Pharmacol. 2015 Dec 15;289(3):361-70. doi: 10.1016/j.taap.2015.10.006. Epub 2015 Oct 23.
7
RLIP76 Targeted Therapy for Kidney Cancer.
Pharm Res. 2015 Oct;32(10):3123-36. doi: 10.1007/s11095-015-1723-1. Epub 2015 May 29.
9
P300 regulates the human RLIP76 promoter activity and gene expression.
Biochem Pharmacol. 2013 Apr 15;85(8):1203-11. doi: 10.1016/j.bcp.2013.02.012. Epub 2013 Feb 16.

本文引用的文献

1
RLIP76 in defense of radiation poisoning.
Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):553-61. doi: 10.1016/j.ijrobp.2008.06.1497.
2
Hsf-1 and POB1 induce drug sensitivity and apoptosis by inhibiting Ralbp1.
J Biol Chem. 2008 Jul 11;283(28):19714-29. doi: 10.1074/jbc.M708703200. Epub 2008 May 12.
3
Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (Ral-binding protein 1).
Cancer Res. 2007 May 1;67(9):4382-9. doi: 10.1158/0008-5472.CAN-06-4124.
4
Mitogenic and drug-resistance mediating effects of PKCalpha require RLIP76.
Biochem Biophys Res Commun. 2006 Sep 22;348(2):722-7. doi: 10.1016/j.bbrc.2006.07.118. Epub 2006 Jul 28.
5
Determinants of differential doxorubicin sensitivity between SCLC and NSCLC.
FEBS Lett. 2006 Apr 17;580(9):2258-64. doi: 10.1016/j.febslet.2006.03.038. Epub 2006 Mar 24.
6
Regression of melanoma in a murine model by RLIP76 depletion.
Cancer Res. 2006 Feb 15;66(4):2354-60. doi: 10.1158/0008-5472.CAN-05-3534.
7
RLIP76 is a major determinant of radiation sensitivity.
Cancer Res. 2005 Jul 15;65(14):6022-8. doi: 10.1158/0008-5472.CAN-05-0968.
8
Depletion of RLIP76 sensitizes lung cancer cells to doxorubicin.
Biochem Pharmacol. 2005 Aug 1;70(3):481-8. doi: 10.1016/j.bcp.2005.05.005.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验